摘要
目的:探讨肝细胞肝癌(HCC)肝切除治疗术中经大网膜静脉注射丝裂霉素(MMC)对预防术后肿瘤复发的价值。方法:回顾分析2000-01-2004-06我院收治的73例HCC行肝切除术患者的临床资料。用药组38例患者术中经大网膜静脉注射10 mg MMC,对照组35例患者未行任何化疗药物注射,随访术后复发情况,并作统计学分析。结果:两组患者的相关临床资料差异无统计学意义,P>0.05。多因素分析提示,术后复发与肿瘤数量及大小有关,危险系数分别为1.877(P=0.001 0)及1.391(P=0.029 4),MMC用药与否对术后复发无明显影响。用药组与对照组术后复发时间用药组和对照组差异无统计学意义,中位无瘤生存时间分别为术后10个月及8个月(P=0.125 3)。用药组和对照组术后1、2、3和5年复发率分别为65.79%6、8.57%(P=0.800 4),81.58%、94.29%(P=0.099 0),89.47%、97.14%(P=0.195 0)和92.11%、97.14%(P=0.344 7)。结论:肝切除术中经大网膜静脉注射MMC(10 mg)对预防HCC术后肿瘤复发可能没有确切价值,但仍有待进一步的前瞻性研究证实。
OBJECTIVE:To estimate the preventive effect of mitomycin C(MMC) injection via great omentum vein during resection of hepatocellular carcinoma(HCC) against the recurrence of HCC.METHODS:The clinical data of 73 HCC patients,who were treated in our hospital form Jan.2000 to Jun.2004,were retrospectively analyzed.Thirty-eight patients were injected with 10 mg MMC via great omentum vein during operation;thirty-five patients who received no chemotherapeutic agents were taken as controls.The recurrence of the disease was followed up and was statistically analyzed.RESULTS:Patients in the 2 groups were matchable(P0.05).Multivariate analysis showed that the recurrence was related to the number and diameter of the tumors,with the hazard ratios being 1.877(P=0.001 0) and 1.391(P=0.029 4),respectively.Injection of MMC had no influence on the recurrence.There was no significant difference in the time of disease-free survival(DFS) between the 2 groups,with the median time of DFS of MMC injection group being 10 months and of con trol group being 8 months after the first operation(P=0.125 3).The recurrence rates in the MMC group and control group were 65.79% vs 68.57%(P=0.800 4) 1 year after operation,81.58% vs 94.29%(P=0.099 0) 2 years after operation,89.47% vs 97.14%(P=0.195 0) 3 years after operation and 92.11% vs 97.14%(P=0.344 7) 5 years after operation.CONCLUSION:Injection of 10 mg MMC via great omentum vein during resection of HCC may have no definite effect on the recurrence of HCC;however,perspective study is needed to verify this finding.
出处
《中华肿瘤防治杂志》
CAS
2010年第22期1862-1864,共3页
Chinese Journal of Cancer Prevention and Treatment
关键词
癌
肝细胞/外科学
肿瘤复发
肝肿瘤/药物疗法
预后
carcinoma
hepatocellular/surgery
neoplasms recurrence
liver neoplasms/drug therapy
prognosis